Customized Services for the Generic Pharmaceutical Industry
CHEMIR provides reverse engineering for Q1/Q2 equivalency of Reference Listed Drugs (RLD) involving topicals (lotions, creams, ointments), transdermal patches, tablets and controlled release delivery. Additionally our customized services feature quantitation of excipients, including hydrocarbon based, polymers, modified cellulose, surfactants and emulsifiers.
CHEMIR will be exhibiting at the Generic Pharmaceutical Association Annual Meeting next week in Orlando, FL. Eric Uffman, Ph.D. and Aaron Cassely, M.S. will be at booth 47 to discuss our reverse engineering and excipient quantitation services for generic pharmaceutical development.
Our scientists will also be glad to discuss our problem solving capabilities, including contaminant/material identification, small scale custom synthesis and customized chemical investigations. CHEMIR experts support intellectual property and product liability legal challenges by providing data review, analytical investigations and expert witness services.